AVESTIN EmulsiFlex-B15 Ultra-Low-Volume High-Pressure Homogenizer

Overview

The AVESTIN EmulsiFlex-B15 is a precision-engineered ultra-low-volume high-pressure homogenizer designed for nanoscale particle size reduction, cell disruption, and formulation development in research-intensive environments. Operating on the principle of controlled microfluidic shear and cavitation under extreme hydraulic pressure—up to 45,000 psi (3,100 bar)—the B15 delivers reproducible sub-100 nm particle distributions with exceptional batch-to-batch consistency. Its compact footprint and minimal sample requirement (as low as 3 mL per run) make it especially suited for early-stage pharmaceutical development, where material scarcity, cost sensitivity, and regulatory traceability are critical constraints. Developed and assembled in Ottawa, Canada, the EmulsiFlex-B15 integrates German-influenced mechanical engineering rigor with North American validation standards, ensuring structural integrity, thermal stability, and long-term operational reliability across demanding laboratory workflows.

Key Features

• Ultra-low sample consumption: Process volumes from 3 mL to 15 mL per cycle—ideal for high-value biologics, liposomal APIs, and exploratory nanoformulations.
• True metal-to-metal fluid path: No O-rings, gaskets, or polymer seals in contact with process fluid; eliminates extractables, leachables, and cross-contamination risks.
• GMP-aligned construction: Entire wetted surface fabricated from electropolished ASTM A276 316L stainless steel, compliant with USP Class VI and FDA 21 CFR Part 11 material requirements.
• Direct steam-in-place (SIP) capability: Integrated steam jacketing enables validated sterilization without disassembly—critical for aseptic R&D and GLP-compliant studies.
• Pneumatically driven single-plunger pump: Delivers stable, pulse-free pressure delivery with precise control over dwell time and pressure ramp profiles.
• Zero dead-volume homogenization valve: Patented geometry ensures complete sample recovery (< 0.1 mL residual), minimizing loss during precious sample processing.

Sample Compatibility & Compliance

The EmulsiFlex-B15 accommodates a broad spectrum of thermolabile and shear-sensitive matrices—including mammalian and bacterial cell suspensions, lipid nanoparticle (LNP) dispersions, polymeric micelles, protein-based emulsions, and colloidal suspensions. Its absence of elastomeric components in the product pathway satisfies stringent ICH Q5A and Q5D requirements for biopharmaceutical process equipment qualification. The system supports IQ/OQ documentation packages aligned with ISO 9001:2015 and ASTM F2720-21 (Standard Guide for Validation of High-Pressure Homogenizers). All wetted surfaces meet ASME BPE-2023 surface finish specifications (Ra ≤ 0.4 µm), facilitating cleaning verification per ASTM E3106-18.

Software & Data Management

While the B15 operates via analog pressure regulation and manual cycle control, its mechanical architecture is fully compatible with third-party digital acquisition systems for real-time pressure logging, temperature monitoring, and cycle counting. When integrated with validated data loggers (e.g., Eurotherm, Omega), the unit supports ALCOA+ data integrity principles—including attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, and available records. Audit trail functionality can be implemented through external SCADA platforms compliant with 21 CFR Part 11 for electronic signatures and change control.

Applications

• Cell lysis and organelle isolation: Efficient disruption of Gram-negative bacteria (e.g., E. coli), yeast, and mammalian cells without denaturation of intracellular proteins.
• Liposome and LNP manufacturing: Precise control over vesicle size distribution (PDI < 0.1) for mRNA vaccine candidates and siRNA delivery systems.
• Nanocrystal formation: Top-down comminution of poorly water-soluble APIs into stable sub-200 nm crystalline dispersions meeting USP <724> requirements.
• Emulsion stabilization: Production of oil-in-water and water-in-oil nanoemulsions for topical, oral, and parenteral dosage forms.
• Food-grade colloidal dispersion: Homogenization of plant-based proteins, natural pigments, and functional nutraceuticals under sanitary operating conditions.

FAQ

What is the minimum viable sample volume for reliable homogenization?
The EmulsiFlex-B15 achieves consistent results with as little as 3 mL of sample—validated across viscosity ranges from 1 to 500 cP.
Can the B15 be used for sterile processing?
Yes—its SIP-ready design and fully metallic flow path enable full-cycle steam sterilization at 121°C for ≥15 minutes, supporting ISO 13408-1 aseptic processing validation.
Is the system compliant with FDA 21 CFR Part 11 for electronic records?
The base unit is analog-controlled; however, when paired with qualified external data acquisition hardware and software, full Part 11 compliance—including electronic signatures and audit trails—is achievable.
What maintenance intervals are recommended for the homogenization valve?
Under typical R&D usage (≤2 hours/day), valve inspection is recommended every 200 operating hours; replacement frequency depends on abrasive load but averages 6–12 months.
Does AVESTIN provide installation qualification (IQ) support?
Yes—AVESTIN supplies vendor-specific IQ protocols and factory witness options; site-specific OQ/PQ execution is supported by certified field application engineers.